ARTICLE | Financial News
Checkmate raises $27M in series B
June 16, 2017 9:29 PM UTC
Immuno-oncology play Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) raised $27 million on June 15 in a series B round led by new investor F-Prime Capital Partners. Existing investors Sofinnova Ven...
BCIQ Company Profiles